Airway Microbe May Prime Lungs Against Pneumonia
Researchers at the University of Colorado Anschutz found that Prevotella melaninogenica, a bacterium common in healthy mouths and airways, altered mouse lung immune cells. After exposure, mice cleared Streptococcus pneumoniae more effectively. The work suggests respiratory microbiome exposure may train immune defenses and could inform new pneumonia strategies.
Scientists at the University of Colorado Anschutz examined Prevotella melaninogenica, a microbe often present in healthy mouths and airways. In mice, prior exposure to this bacterium was followed by challenge with Streptococcus pneumoniae, a major pneumonia cause. Lung immune cells were then analyzed cell by cell.
The exposed animals' neutrophils and macrophages showed enhanced ability to take up and destroy the pneumonia bacteria, and their lungs held fewer of those pathogens. Earlier human studies have tied richer respiratory microbial communities, including anaerobic groups such as Prevotella, to improved outcomes in severe respiratory disease. The work appears in PNAS.
This work could eventually affect people at risk of bacterial pneumonia and the clinicians who manage respiratory infections. If beneficial airway microbes help train immune defenses, future prevention strategies might seek to support or mimic those effects. Yet the evidence comes from mice, so any human benefit remains uncertain and likely years away. It may mainly guide further microbiome and pneumonia research rather than change care now.